Delayed Treatment with Systemic (S)-Roscovitine Provides Neuroprotection and Inhibits In Vivo CDK5 Activity Increase in Animal Stroke Models
From Roscovitine to CYC202 to Seliciclib – from bench to bedside: discovery and development
Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study - Journal of Cystic Fibrosis
From Roscovitine to CYC202 to Seliciclib – from bench to bedside: discovery and development
Model depicting mechanism of action of R-Roscovitine and its inhibition... | Download Scientific Diagram
Cells | Free Full-Text | Cellular and Molecular Mechanisms of R/S- Roscovitine and CDKs Related Inhibition under Both Focal and Global Cerebral Ischemia: A Focus on Neurovascular Unit and Immune Cells | HTML
Mechanism of action of novel medical treatments for Cushing's disease.... | Download Scientific Diagram
CDK9 activity is critical for maintaining MDM4 overexpression in tumor cells | Cell Death & Disease
Kinase inhibitor roscovitine as a PB2 cap-binding inhibitor against influenza a virus replication - ScienceDirect
The binding pockets and interaction mechanisms of roscovitine in free... | Download Scientific Diagram
Hypothetic scheme of cell death induction pathway triggered roscovitine... | Download Scientific Diagram
Seliciclib - Wikipedia
Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions
Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis. - Abstract - Europe PMC
R)-Roscovitine and CFTR modulators enhance killing of multi-drug resistant Burkholderia cenocepacia by cystic fibrosis macrophages | Scientific Reports
![PDF] CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb30ac1cbae5709f3c8e813bcc2da77ce6b5f3cd/3-Figure2-1.png "PDF] CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases | Semantic Scholar")
PDF] CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases | Semantic Scholar
Frontiers | CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas | Pharmacology
Roscovitine attenuates intimal hyperplasia via inhibiting NF-κB and STAT3 activation induced by TNF-α in vascular smooth muscle cells - ScienceDirect
Roscovitine (Seliciclib,CYC202) | CAS:186692-46-6 | CDK inhibitor,potent and selective | High Purity | Manufacturer BioCrick
Inhibition of CDK5 Alleviates the Cardiac Phenotypes in Timothy Syndrome - ScienceDirect
